VRCA
Verrica Pharmaceuticals Inc.
+0.13 (+2.87%)4.66USD20.2K成交股數80.1M市值–本益比(近四季)2.6股價營收比-53.9%營收年增(近四季)2026-11-13下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 5.9M-54% | 5.0M+46% | 5.1M-386% | 14.3M+177% | 12.7M+232% | 3.4M+73% | −1.8M-161% | 5.2M+2745% | 3.8M | 2.0M | 2.9M | 182K |
| 營業成本 | – | – | – | – | – | 700K | 400K | 700K | 700K | – | 300K | – |
| 毛利 | – | – | – | – | – | 2.7M | −2.2M-183% | 4.5M | 3.1M | – | 2.6M | – |
| 毛利率 | – | – | – | – | – | 79.6% | 122.5% | 86.5% | 81.7% | – | 89.7% | – |
| 研發費用 | 6.0M | 3.9M | 2.5M | 2.2M | 1.8M | 2.3M | 2.4M | 3.3M | 4.9M | 5.3M | 6.5M | 5.7M |
| 銷售管理費用 | 10.3M | 10.0M | 8.1M | 9.4M | 8.9M | 8.8M | 16.1M | 16.5M | 16.3M | 17.0M | 20.1M | 5.9M |
| 營業利益 | −13.1M-967% | −9.7M+19% | −7.2M-65% | 1.6M-111% | 1.5M-108% | −8.1M-65% | −20.7M-13% | −15.2M+31% | −18.6M | −23.1M | −23.9M | −11.6M |
| 營業利益率 | -223.4% | -193.4% | -141.2% | 11.3% | 11.9% | -236.4% | 1,162.5% | -293.7% | -486.1% | -1,163.8% | -819.9% | -6,382.4% |
| 稅後淨利 | −13.2M-6548% | −9.7M-1% | −8.1M-65% | −274K-98% | 204K-101% | −9.7M-60% | −22.9M-8% | −17.2M+56% | −20.3M | −24.6M | −24.8M | −11.0M |
| 淨利率 | -224.4% | -192.8% | -158.8% | -1.9% | 1.6% | -283.3% | 1,283.5% | -332.0% | -531.4% | -1,238.4% | -850.3% | -6,038.5% |
| 稀釋 EPS | -0.62-3200% | -0.45-56% | -0.64-87% | -0.03-99% | 0.02-105% | -1.03+87% | -4.88+804% | -3.70+1442% | -0.44 | -0.55 | -0.54 | -0.24 |
| 稀釋股數 | 21.3M | 21.3M | 10.7M | 9.5M | 9.5M | 9.5M | 4.7M | 4.7M | 46.5M | 45.3M | 46.1M | 45.9M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 11.2M | 20.6M | 30.1M | 21.1M | 15.4M | 29.6M | 23.0M | 31.9M | 48.9M | 69.5M | 84.3M | 55.1M |
| 應收帳款 | 10.9M | 7.7M | 5.3M | 7.0M | 9.2M | 5.6M | 0.00 | 10.0M | 7.0M | 4.2M | 3.9M | – |
| 存貨 | 2.7M | 2.0M | 2.2M | 2.3M | 2.5M | 2.5M | 2.6M | 2.7M | 2.5M | 1.0M | 279K | – |
| 總資產 | 36.0M | 38.8M | 47.1M | 40.9M | 39.1M | 42.2M | 32.9M | 52.0M | 66.3M | 81.6M | 97.1M | 62.2M |
| 有息負債 | – | – | 0.00 | 21.6M | 24.6M | 27.8M | 43.3M | 42.8M | 42.8M | 42.9M | 42.4M | – |
| 總負債 | 31.7M | 22.7M | 22.4M | 57.9M | 56.6M | 60.8M | 67.0M | 65.3M | 64.8M | 61.8M | 54.8M | 6.8M |
| 股東權益 | 4.3M | 16.1M | 24.7M | −17.0M | −17.5M | −18.6M | −34.1M | −13.3M | 1.5M | 19.8M | 42.3M | 55.4M |
| 負債比 | 88.0% | 58.6% | 47.5% | 141.7% | 144.7% | 144.0% | 203.4% | 125.6% | 97.7% | 75.8% | 56.5% | 10.9% |
| 淨現金(現金 − 有息負債) | – | – | 30.1M | −522K | −9.2M | 1.8M | −20.3M | −10.8M | 6.1M | 26.7M | 41.9M | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −9.2M-28% | – | – | – | −12.7M | – | – | −19.9M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | 0.00 | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | −19.9M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | -521.4% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 35.6M
| Operating | 35.6M | 100.0% | +370.2% |
|---|
產品／服務2025 年度 · 35.6M
| License And Collaboration Revenue | 20.3M | 57.0% | +1945.6% |
|---|---|---|---|
| 產品 | 15.3M | 43.0% | +132.5% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 35.6M | +370.2% | −17.9M | -50.3% | -1.68 | −17.6M |
| FY2024 | 7.6M | +47.7% | −76.6M | -1,012.4% | -14.78 | −61.0M |
| FY2023 | 5.1M | -43.3% | −67.0M | -1,307.6% | -1.48 | −38.9M |
| FY2022 | 9.0M | -24.7% | −24.5M | -271.1% | -0.72 | −19.0M |
| FY2021 | 12.0M | – | −35.1M | -292.3% | -1.30 | −28.5M |
| FY2020 | – | – | −42.7M | –% | -1.71 | −31.7M |
| FY2019 | – | – | −28.2M | –% | -1.13 | −28.1M |
| FY2018 | – | – | −20.6M | –% | -1.41 | −18.6M |